Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Return on Equity (2016 - 2025)

Zevra Therapeutics' Return on Equity history spans 10 years, with the latest figure at 0.58% for Q4 2025.

  • For Q4 2025, Return on Equity rose 251.0% year-over-year to 0.58%; the TTM value through Dec 2025 reached 0.58%, up 251.0%, while the annual FY2025 figure was 0.86%, 294.0% up from the prior year.
  • Return on Equity reached 0.58% in Q4 2025 per ZVRA's latest filing, up from 0.28% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.58% in Q4 2025 to a low of 2.28% in Q1 2025.
  • Average Return on Equity over 5 years is 0.59%, with a median of 0.27% recorded in 2021.
  • Peak YoY movement for Return on Equity: tumbled -219bps in 2021, then surged 251bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.07% in 2021, then soared by 423bps to 0.24% in 2022, then plummeted by -415bps to 0.75% in 2023, then tumbled by -158bps to 1.93% in 2024, then surged by 130bps to 0.58% in 2025.
  • Per Business Quant, the three most recent readings for ZVRA's Return on Equity are 0.58% (Q4 2025), 0.28% (Q3 2025), and 0.03% (Q2 2025).